Technology | December 23, 2009

Drug Reference Application Available for Android

December 24, 2009 – A clinical reference and pharmaceutical database application was released this week for the Google Android personal digital assistant (PDA) device.

Lexi-Comp ON-HAND for Android features Lexi-Drugs, a comprehensive pharmacology database. Users can create and store personalized user notes within each monograph, as well as diagnose, find treatment options, and identify drug interactions in seconds. Databases stored on the memory card allow for quick access to the equivalent of more than 65,000 printed pages of the most updated clinical information available on a smartphone.

The application allows users to view tables, charts, appendices, and images as they are seen in Lexi-Comp’s handbooks and Internet platforms. Also, downloading and updating the software is now done over the air, with no cords or syncing required.

With Lexi-Comp ON-HAND software, clinicians can link to FDA warnings, PubMed, and additional resources directly from their phone. Additional licensed resources include “Harrison’s Practice,” “The 5-Minute Clinical Consultant,” and “Stedman’s Medical Dictionary” for the “Health Professions and Nursing.”

This platform expands Lexi-Comp’s handheld solution, which also includes compatibility with the iPod touch, smartphones including iPhone, BlackBerry and Windows Mobile, as well as Palm, Pocket PC devices, and any device with Web browser capabilities.

For more information: www.lexi.com/pda/google-android

Related Content

Effect of Daily Aspirin on First-Time Heart Attack and Stroke Risk Inconclusive
News | Pharmaceuticals | September 04, 2018
The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to...
Blood Pressure and Cholesterol-lowering Drugs Continue to Improve Survival After a Decade
News | Pharmaceuticals | August 27, 2018
Blood pressure and cholesterol-lowering drugs continue to improve survival in patients with hypertension after more...
Pfizer Announces Positive Topline Results from Phase 3 ATTR-ACT Study
News | Pharmaceuticals | April 06, 2018
Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met its primary endpoint...
Humanetics Presents Data on Drug to Protect Cardiac Cells From Space-Like Radiation

Photo from NASA

News | Pharmaceuticals | February 01, 2018
February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the Natio
Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals | October 18, 2017
October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...
News | Pharmaceuticals | October 04, 2017
October 4, 2017 — MyoKardia Inc.
News | Pharmaceuticals | September 12, 2017
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in pati
Merck Announces Results of REVEAL Outcomes Study of Anacetrapib
News | Pharmaceuticals | September 11, 2017
Merck and researchers in the Clinical Trial Service Unit at the University of Oxford announced the publication and...
Statins Associated With Improved Heart Structure and Function
News | Pharmaceuticals | May 26, 2017
Statins are associated with improved heart structure and function, according to research presented at EuroCMR 2017, May...
Feature | Pharmaceuticals | May 16, 2017
May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal
Overlay Init